Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2024 Results
May 09, 2024 07:00 ET
|
Allegro MicroSystems, Inc.
– Full Year 2024 Sales Increase 8% to a Record $1.05 Billion ––38% Growth in E-Mobility Drives 17% Year-over-Year Increase in Full Year 2024 Automotive Sales – MANCHESTER, N.H., May 09,...
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
May 09, 2024 07:00 ET
|
Renalytix plc
LONDON and SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its third quarter fiscal year 2024 financial results on Wednesday,...
Advantage Solutions Reports First Quarter Results with New Reporting Segments and Reaffirms its 2024 Outlook
May 09, 2024 07:00 ET
|
Advantage Solutions, Inc.
Management reaffirms its 2024 outlook as first-quarter results met expectations despite soft market conditions and higher-than-expected costs and investments.Inclusive of discontinued operations,...
Optinose Announces $55 Million Registered Direct Offering
May 09, 2024 07:00 ET
|
Optinose, Inc.
Led by Nantahala Capital and The D. E. Shaw Group with participation from existing and new investors Post-offering cash balance of ~$100 million expected to fund operating plan through 2025 ...
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
May 09, 2024 07:00 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...
BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024
May 09, 2024 07:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
May 09, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO®...
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
May 09, 2024 07:00 ET
|
TScan Therapeutics, Inc.
Patient dosed with TSC-203-A0201 targeting cancer-associated antigen PRAME On-track to report initial data from the solid tumor clinical trial in 2024 WALTHAM, Mass., May ...
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
May 09, 2024 07:00 ET
|
Verona Pharma plc
Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine’s clinical activities Cash runway extended beyond 2026 LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE...
NOWPayments Enables Cryptocurrency Purchases of Tangem Wallets: Expanding Payment Options with BTC, ETH, USDC, and More
May 09, 2024 07:00 ET
|
NOWPayments
Victoria, Seychelles , May 09, 2024 (GLOBE NEWSWIRE) -- NOWPayments, a leading crypto payment gateway, is proud to announce a strategic partnership with Tangem, the world’s leading provider of...